Olga V. Orlova
Moscow, MOW, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Effect of the C12L, A35R, A40R, and A41L Genes of MVA Vector on the Immunogenicity of Recombinant MVA Expressing the SARS-CoV-2 Spike Protein.
Journal: Bulletin of experimental biology and medicine
Published: March 04, 2025
An MVA-Based Vector Expressing the SARS-CoV-2 RBD Fused to N Protein Induces Neutralizing Antibodies and T-Cell Immune Response in Mice.
Journal: Bulletin of experimental biology and medicine
Published: January 21, 2025
Dynamics of Transgene Expression in the MVA Vaccine Vector under the Control of the p11, p13.5, pLEO160, p7.5, and mH5 Promoters and Independence of the Transgene Expression Level from the Insertion Locus
Journal: Molekuliarnaia biologiia
Published: June 14, 2024
Development of MVA-d34 Tetravalent Dengue Vaccine: Design and Immunogenicity.
Journal: Vaccines
Published: March 17, 2023
Development of Modified Vaccinia Virus Ankara-Based Vaccines: Advantages and Applications.
Journal: Vaccines
Published: August 05, 2022
Application of real-time PCR to significantly reduce the time to obtain recombinant MVA virus.
Journal: Journal of virological methods
Published: August 06, 2020
Consensus guidelines for botulinum toxin therapy: general algorithms and dosing tables for dystonia and spasticity.
Journal: Journal of neural transmission (Vienna, Austria : 1996)
Published: June 26, 2020
Characterization of the 20S proteasome of the lepidopteran, Spodoptera frugiperda.
Journal: Biochimica et biophysica acta. Proteins and proteomics
Published: March 05, 2019
Last Updated: 09/26/2026